North Financial Statements From 2010 to 2026
Analyzing historical trends in various income statement and balance sheet accounts from North American's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting North American's valuation are summarized below:North American Cannabis does not presently have any fundamental ratios for analysis.
This module can also supplement various North American Technical models . Check out the analysis of North American Correlation against competitors.
Check North American financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among North American's main balance sheet or income statement drivers, such as , as well as many indicators such as . North financial statements analysis is a perfect complement when working with North American Valuation or Volatility modules.
North |
North American Cannabis Company Current Valuation Analysis
North American's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current North American Current Valuation | 2.29 M |
Most of North American's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, North American Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, North American Cannabis has a Current Valuation of 2.29 M. This is 99.98% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
North American Cannabis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining North American's current stock value. Our valuation model uses many indicators to compare North American value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across North American competition to find correlations between indicators driving North American's intrinsic value. More Info.North American Cannabis is rated first in current valuation category among its peers. It is rated first in shares outstanding category among its peers creating about 10,000 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the North American's earnings, one of the primary drivers of an investment's value.About North American Financial Statements
Investors use fundamental indicators, such as North American's revenue or net income, to determine how well the company is positioned to perform in the future. Although North American's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
North American Cannabis Holdings, Inc., through its subsidiaries, operates in the legal cannabis market in the United States. North American Cannabis Holdings, Inc. was formerly known as Algae International Group, Inc. and changed its name to North American Cannabis Holdings, Inc. in June 2015. North American is traded on OTC Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in North Pink Sheet
North American financial ratios help investors to determine whether North Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in North with respect to the benefits of owning North American security.